{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:02:23Z","timestamp":1747206143705,"version":"3.40.5"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s197735","type":"journal-article","created":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T21:25:35Z","timestamp":1557696335000},"page":"1257-1264","source":"Crossref","is-referenced-by-count":4,"title":["<p>Cefuroxime compared to piperacillin\/tazobactam as empirical treatment of <em>Escherichia coli<\/em> bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort<\/p>"],"prefix":"10.2147","volume":"Volume 12","author":[{"given":"Sara","family":"Th\u00f8nnings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-9996","authenticated-orcid":true,"given":"Filip","family":"Jans\u00e5ker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-2031","authenticated-orcid":true,"given":"Kim Oren","family":"Gradel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarne","family":"Styrishave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-9956","authenticated-orcid":true,"given":"Jenny Dahl","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,5]]},"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=49824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=49824","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T21:25:37Z","timestamp":1557696337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/cefuroxime-compared-to-piperacillintazobactam-as-empirical-treatment-o-peer-reviewed-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/idr.s197735","relation":{},"ISSN":["1178-6973"],"issn-type":[{"type":"electronic","value":"1178-6973"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}